| Product |
ISTALOL (Bausch & Lomb Incorporated), TIMOPTIC (Bausch & Lomb Incorporated), TIMOPTIC-XE (Bausch & Lomb Incorporated), TIMOPTIC IN OCUDOSE (Bausch & Lomb Incorporated), TIMOPTIC IN OCUDOSE (Bausch Health US LLC), TIMOLOL GFS (Sandoz) |
| Generic |
TIMOLOL MALEATE (A-S Medication Solutions), TIMOLOL MALEATE (A-S Medication Solutions), TIMOLOL MALEATE (A-S Medication Solutions), TIMOLOL MALEATE (A-S Medication Solutions), TIMOLOL MALEATE (Akorn), TIMOPTIC IN OCUDOSE (Amring Pharmaceuticals), TIMOLOL MALEATE (Apotex Corp), TIMOLOL MALEATE (Ascend Laboratories), TIMOLOL MALEATE (Athem LLC), TIMOLOL MALEATE (BAUSCH & LOMB INCORPORATED), TIMOLOL MALEATE (Bausch & Lomb Americas), TIMOLOL MALEATE (Bausch & Lomb Americas), TIMOLOL MALEATE (Bausch & Lomb Americas), TIMOLOL MALEATE (Bausch & Lomb Americas), TIMOLOL MALEATE (Bausch & Lomb Incorporated), TIMOLOL MALEATE (Bryant Ranch Prepack), TIMOLOL MALEATE (Medsource Pharmaceuticals), TIMOLOL MALEATE (Mylan Pharmaceuticals), TIMOLOL MALEATE (Oceanside Pharmaceuticals), TIMOLOL MALEATE (Oceanside Pharmaceuticals), TIMOLOL MALEATE (Pacific Pharma), TIMOLOL MALEATE (Rising Pharmaceuticals), TIMOLOL MALEATE (Sandoz), TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION (Gland Pharma Limited), TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25% (Alembic Pharmaceuticals) |
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA06 Timolol
D00603 Timolol maleate (JP18/USP) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01ED Beta blocking agents
S01ED01 Timolol
D00603 Timolol maleate (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Antimigraine Agents
Antimigraine Agents, Other
Timolol
D00603 Timolol maleate (JP18/USP)
Cardiovascular Agents
Beta-adrenergic Blocking Agents
Non-Selective
Timolol
D00603 Timolol maleate (JP18/USP)
Ophthalmic Agents
Intraocular Pressure Lowering Agents
Beta-adrenergic Blocking Agents, Ophthalmic
Timolol
D00603 Timolol maleate (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D00603 Timolol maleate (JP18/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG00306 Timolol
D00603 Timolol maleate
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG00306 Timolol
D00603 Timolol maleate
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00306 Timolol
D00603 Timolol maleate
Drug classes [BR:br08332]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
D00603 Timolol maleate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB1
D00603 Timolol maleate (JP18/USP) <JP/US>
ADRB2
D00603 Timolol maleate (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00603 Timolol maleate
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00603
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG00306 Timolol
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG00306 Timolol
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00306 Timolol
|